Statistics for Top 10 Results
Filter:
Domain Registration Date Filter
1
5-year follow-up from the randomized phase III KEYNOTE-177 study
https://pubmed.ncbi.nlm.nih.gov/39631622/
2
5-year follow-up from the randomized phase III KEYNOTE-177 study
https://www.annalsofoncology.org/article/S0923-7534%252824%252904949-4/fulltext
3
Pembrolizumab versus chemotherapy in microsatellite instability-high or ...
https://pure.johnshopkins.edu/en/publications/pembrolizumab-versus-chemotherapy-in-microsatellite-instability-h/
4
5-year follow-up from the randomized phase III KEYNOTE-177 study
https://www.researchgate.net/publication/386354014_Pembrolizumab_Versus_chemotherapy_in_microsatellite_instability-high_or_mismatch_repair-deficient_metastatic_colorectal_cancer_5-year_follow-up_from_the_randomized_phase_3_KEYNOTE-177_study
5
KEYNOTE-177 - Clinical Trial Results | HCP
https://www.keytrudahcp.com/efficacy/msi-h-dmmr-colorectal-cancer/
6
What is the significance of mismatch repair deficiency in stage IV colon ...
https://pmc.ncbi.nlm.nih.gov/articles/PMC11921172/
7
Review Article Impact of Neoadjuvant Immunotherapy in Localized Rectal ...
https://www.sciencedirect.com/science/article/pii/S1533002825000738
8
Nivolumab plus ipilimumab versus nivolumab in microsatellite ...
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02848-4/abstract
9
The neoadjuvant immunotherapy for non-metastatic mismatch repair ...
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1540751/full
10
[PDF] A Phase 1/2 Open-label Study of NDI-219216, a WRN Inhibitor, in ...
https://www.nimbustx.com/wp-content/uploads/WRN-TiP_ESMO-Poster.pdf